3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
20
Lung Neoplasms
15
Carcinoma, Hepatocellular
13
Urinary Bladder Neoplasms
11
Colorectal Neoplasms
11
Small Cell Lung Carcinoma
9
Neoplasms
8
Carcinoma, Transitional Cell
8
Stomach Neoplasms
7
Neoplasm Metastasis
7
Breast Neoplasms
6
Triple Negative Breast Neoplasms
5
Melanoma
5
Prostatic Neoplasms
4
Glioblastoma
4
Carcinoma, Renal Cell
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Ovarian Neoplasms
3
Carcinoma, Neuroendocrine
3
Urethral Neoplasms
2
Ureteral Neoplasms
2
Turcot syndrome
2
Solid Tumors
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Nasopharyngeal Carcinoma
2
Mesothelioma, Malignant
2
Lymphoma, Follicular
2
Glioma
2
Interventions
Paclitaxel
8
Radiotherapy
7
Cisplatin
6
pembrolizumab
4
Fluorouracil
4
Surgical Procedures, Operative
3
Radiation
3
Oxaliplatin
3
Levoleucovorin
3
Leucovorin
3
Esophagectomy
3
Drug Therapy
3
Carboplatin
3
lenvatinib
2
durvalumab
2
Taxes
2
TP protocol
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Neoadjuvant Therapy
2
Irinotecan
2
Capecitabine
2
trifluridine tipiracil drug combination
1
tislelizumab
1
palbociclib
1
osimertinib
1
obinutuzumab
1
nedaplatin
1
naptumomab estafenatox
1
futibatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Esophageal Squamous Cell Carcinoma
×
atezolizumab
×
Clear all
NCT04543617
2026-04-17
SKYSCRAPER-07
Hoffmann-La Roche
Phase 3
Active not recruiting
760 enrolled